CTLA4 and hypophysitis: In regard to hypophysitis as described in adults, it has been found to occur more commonly with anti-CTLA-4 agents (ranging from 3.0–10.0 %) and combination therapy (approximately 7.0 %), but no pediatric cases have been reported thus far [17, 30, 49].